Alex M. Azar II

Executive

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 1 sale

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (2 ops.)

€135k

Latest filing published 15 Oct 2026 for Guardant Health, Inc., €9,843. Read the official filing

Filing timeline

BuySale

Alex M. Azar II

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Alex M. Azar II: trading record in brief

Alex M. Azar II appears in our data through filings on Guardant Health, Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 12 September 2026 and the latest from 14 October 2026.

On the market, this insider has only sold: 2 sales, €135k in total. The rest of the record consists of 2 option exercises.

Most recently, on 15 October 2026, the filings show an open-market sale worth €9,843 in Guardant Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.